1,720,991 research outputs found
sj-pdf-1-cep-10.1177_03331024211046618 - Supplemental material for Clinical correlates of hypothalamic functional changes in migraine patients
No full textSupplemental material, sj-pdf-1-cep-10.1177_03331024211046618 for Clinical correlates of hypothalamic functional changes in migraine patients by Roberta Messina, Maria A Rocca, Paola Valsasina, Paolo Misci and Massimo Filippi in Cephalalgia</p
sj-pdf-6-cep-10.1177_03331024231152169 - Supplemental material for Safety and tolerability of monoclonal antibodies targeting the CGRP pathway and gepants in migraine prevention: A systematic review and network meta-analysis
No full textSupplemental material, sj-pdf-6-cep-10.1177_03331024231152169 for Safety and tolerability of monoclonal antibodies targeting the CGRP pathway and gepants in migraine prevention: A systematic review and network meta-analysis by Roberta Messina, Eva-Maria Huessler, Francesca Puledda, Faraidoon Haghdoost, Elena R Lebedeva and Hans-Christoph Diener in Cephalalgia</p
sj-jpg-4-cep-10.1177_03331024231152169 - Supplemental material for Safety and tolerability of monoclonal antibodies targeting the CGRP pathway and gepants in migraine prevention: A systematic review and network meta-analysis
No full textSupplemental material, sj-jpg-4-cep-10.1177_03331024231152169 for Safety and tolerability of monoclonal antibodies targeting the CGRP pathway and gepants in migraine prevention: A systematic review and network meta-analysis by Roberta Messina, Eva-Maria Huessler, Francesca Puledda, Faraidoon Haghdoost, Elena R Lebedeva and Hans-Christoph Diener in Cephalalgia</p
sj-pdf-2-cep-10.1177_03331024231159366 - Supplemental material for Evaluating the efficacy of CGRP mAbs and gepants for the preventive treatment of migraine: A systematic review and network meta-analysis of phase 3 randomised controlled trials
No full textSupplemental material, sj-pdf-2-cep-10.1177_03331024231159366 for Evaluating the efficacy of CGRP mAbs and gepants for the preventive treatment of migraine: A systematic review and network meta-analysis of phase 3 randomised controlled trials by Faraidoon Haghdoost, Francesca Puledda, David Garcia-Azorin, Eva-Maria Huessler, Roberta Messina and Patricia Pozo-Rosich in Cephalalgia</p
sj-pdf-1-cep-10.1177_03331024231159366 - Supplemental material for Evaluating the efficacy of CGRP mAbs and gepants for the preventive treatment of migraine: A systematic review and network meta-analysis of phase 3 randomised controlled trials
No full textSupplemental material, sj-pdf-1-cep-10.1177_03331024231159366 for Evaluating the efficacy of CGRP mAbs and gepants for the preventive treatment of migraine: A systematic review and network meta-analysis of phase 3 randomised controlled trials by Faraidoon Haghdoost, Francesca Puledda, David Garcia-Azorin, Eva-Maria Huessler, Roberta Messina and Patricia Pozo-Rosich in Cephalalgia</p
sj-jpg-5-cep-10.1177_03331024231152169 - Supplemental material for Safety and tolerability of monoclonal antibodies targeting the CGRP pathway and gepants in migraine prevention: A systematic review and network meta-analysis
No full textSupplemental material, sj-jpg-5-cep-10.1177_03331024231152169 for Safety and tolerability of monoclonal antibodies targeting the CGRP pathway and gepants in migraine prevention: A systematic review and network meta-analysis by Roberta Messina, Eva-Maria Huessler, Francesca Puledda, Faraidoon Haghdoost, Elena R Lebedeva and Hans-Christoph Diener in Cephalalgia</p
sj-jpg-1-cep-10.1177_03331024231152169 - Supplemental material for Safety and tolerability of monoclonal antibodies targeting the CGRP pathway and gepants in migraine prevention: A systematic review and network meta-analysis
No full textSupplemental material, sj-jpg-1-cep-10.1177_03331024231152169 for Safety and tolerability of monoclonal antibodies targeting the CGRP pathway and gepants in migraine prevention: A systematic review and network meta-analysis by Roberta Messina, Eva-Maria Huessler, Francesca Puledda, Faraidoon Haghdoost, Elena R Lebedeva and Hans-Christoph Diener in Cephalalgia</p
sj-jpg-2-cep-10.1177_03331024231152169 - Supplemental material for Safety and tolerability of monoclonal antibodies targeting the CGRP pathway and gepants in migraine prevention: A systematic review and network meta-analysis
No full textSupplemental material, sj-jpg-2-cep-10.1177_03331024231152169 for Safety and tolerability of monoclonal antibodies targeting the CGRP pathway and gepants in migraine prevention: A systematic review and network meta-analysis by Roberta Messina, Eva-Maria Huessler, Francesca Puledda, Faraidoon Haghdoost, Elena R Lebedeva and Hans-Christoph Diener in Cephalalgia</p
sj-jpg-3-cep-10.1177_03331024231152169 - Supplemental material for Safety and tolerability of monoclonal antibodies targeting the CGRP pathway and gepants in migraine prevention: A systematic review and network meta-analysis
No full textSupplemental material, sj-jpg-3-cep-10.1177_03331024231152169 for Safety and tolerability of monoclonal antibodies targeting the CGRP pathway and gepants in migraine prevention: A systematic review and network meta-analysis by Roberta Messina, Eva-Maria Huessler, Francesca Puledda, Faraidoon Haghdoost, Elena R Lebedeva and Hans-Christoph Diener in Cephalalgia</p
- …
